SCHEDULE 13G/A
Statement of Beneficial Ownership
Perspective Therapeutics, Inc. Filed Acc 0002012383-26-001695
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BlackRock, Inc. | 5,251,363 | 4.6% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-12 SCHEDULE 13D/A · Lantheus Holdings, Inc. 3.9%
- 2026-11-10 SCHEDULE 13G · STATE STREET CORPORATION 1.8%
- 2026-09-23 SCHEDULE 13D/A · Lantheus Holdings, Inc. 7.7%
- 2026-09-04 SCHEDULE 13D/A · Lantheus Holdings, Inc. 10.0%
- 2026-08-13 SCHEDULE 13G/A · Millennium Management LLC 5.5%
- 2026-08-07 SCHEDULE 13G · STATE STREET CORPORATION 5.3%
- 2026-07-29 SCHEDULE 13G · BlackRock, Inc. 6.8%
- 2026-07-20 SCHEDULE 13G · Millennium Management LLC 5.3%
- 2026-06-30 SCHEDULE 13G · Millennium Management LLC 4.3%
- 2026-05-12 SCHEDULE 13G/A · Morgan Stanley 2.6%
- 2026-04-27 SCHEDULE 13G/A · BlackRock, Inc. 4.6%
- 2026-03-10 SCHEDULE 13G · Avidity Partners Management LP 5.3%
- 2026-02-12 SCHEDULE 13G · Morgan Stanley 6.0%
- 2026-02-09 SCHEDULE 13G · Commodore Capital LP 9.9%
- 2026-02-06 SCHEDULE 13G · Chen Yu 6.9%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…